Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors. 1996

P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
Unité 127 Institut National de la Santé et de la Recherche Médicale, Hôpital Lariboisière, Paris, France.

Heart rate variability (HRV) depends on various reflexes, including the baroreflex or respiratory reflex. Experimental studies have suggested that the sinoatrial node density in G protein-linked receptors may be involved. Transgenic mice, with a specific eightfold atrial overexpression of human beta 1-adrenoceptor (beta 1-AR), have been generated to evaluate the role of the atrial beta 1-AR density on HRV. The heart rate was monitored using telemetry, and the signal was analyzed using a quantitative time-frequency domain analysis, the smoothed pseudo-Wigner-Ville method, and phase portrait maps. 1) Heart rate was unchanged, but the two normal components of HRV were decreased in transgenic mice. Transgenic mice have an unshortened life span and no arrhythmias. 2) Challenge of the animals by propranolol showed no modulation of the HRV in transgenic mice compared with controls. 3) In isolated atrial strips from transgenic mice, basal contractility was increased and there was no isoproterenol-induced inotropic effect. 4) The basal level of adenosine 3',5'-cyclic monophosphate production was lowered in transgenic mice, suggesting a shift in adenylate cyclase isoforms.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011941 Receptors, Adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction. Adrenergic Receptors,Adrenoceptor,Adrenoceptors,Norepinephrine Receptor,Receptors, Epinephrine,Receptors, Norepinephrine,Adrenergic Receptor,Epinephrine Receptors,Norepinephrine Receptors,Receptor, Adrenergic,Receptor, Norepinephrine
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right

Related Publications

P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
March 2000, Journal of the autonomic nervous system,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
September 1993, Cardiovascular research,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
October 2007, International journal of cardiology,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
July 2000, Diabetologia,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
August 2008, Free radical biology & medicine,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
December 1999, European journal of cancer (Oxford, England : 1990),
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
September 2002, The Journal of clinical investigation,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
February 2001, American journal of physiology. Endocrinology and metabolism,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
October 2010, Diabetes,
P Mansier, and C Médigue, and N Charlotte, and C Vermeiren, and E Coraboeuf, and E Deroubai, and E Ratner, and B Chevalier, and J Clairambault, and F Carré, and T Dahkli, and B Bertin, and P Briand, and D Strosberg, and B Swynghedauw
February 1994, Behavioral neuroscience,
Copied contents to your clipboard!